NEUROMAMA, LTD. EBITDA
- 2013-10-31: Basis Reported; EBITDA (m); Operating income -$360.45K; Depreciation and amortization (m).
- 2013-07-31: Basis Reported; EBITDA (m); Operating income -$129.55K; Depreciation and amortization (m).
- 2012-10-31: Basis Reported; EBITDA (m); Operating income -$4.61K; Depreciation and amortization (m).
- 2012-07-31: Basis Reported; EBITDA (m); Operating income -$1.54K; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2013-10-31 | Reported | (m) | -$360.45K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-07-31 | Reported | (m) | -$129.55K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2012-10-31 | Reported | (m) | -$4.61K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2012-07-31 | Reported | (m) | -$1.54K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|